Introduction of the Misgav Ladach caesarean section at an African tertiary centre: a randomised controlled trial.
OBJECTIVE
To determine whether the Misgav Ladach caesarean section technique can offer benefits compared with conventional caesarean section technique in the prevailing conditions of a busy African tertiary centre.


METHODS
A randomised controlled trial.


METHODS
A tertiary African obstetric unit with 18,000 deliveries annually.


METHODS
Three hundred and thirty-nine women undergoing caesarean section.


METHODS
Eight residents and registrars were instructed in the Misgav Ladach technique for caesarean section during one week, after which the study commenced. The course participants instructed their colleagues; in total, 16 doctors participated. Women requiring caesarean section were randomised to Misgav Ladach or to the conventional lower midline incision procedure, excluding those with a previous scar.


RESULTS
During 11 weeks 339 randomised procedures (328 of which were emergency procedures) were carried out. Mean operating time was 25 x 3 minutes for Misgav Ladach and 32 x 6 minutes for the lower midline incision procedure (95% CI -8 x 3; -6 x 3). Mean blood loss was 354 mL and 447 mL (-133; -53), and the number of sutures 3 x 1 and 6 x 1 (-3 x 1; -2 x 9), respectively. No significant difference was found in Apgar scores. Mobilisation was earlier with the Misgav Ladach procedure. No difference was found in overall post-operative infection rates i.e. wound infection or febrile illness, but the combination of wound infection and fever was more common in the Misgav Ladach group.


CONCLUSIONS
The Misgav Ladach caesarean section confers benefits such as reduced blood loss, conservation of time and suture material, and rapid mobilisation, but more studies are needed to explore modifications aimed at reducing post-operative infections in settings with limited resources.
Björklund
K
K
Department of Women's and Children's Health, Section of Obstetrics and Gynecology, Uppsala University, Sweden.
Kimaro
M
M
Urassa
E
E
Lindmark
G
G
D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016063:Blood Loss, Surgical / Q000517:prevention & control; D002585:Cesarean Section / Q000379:methods*; D005260:Female; D006801:Humans; D011247:Pregnancy; D011248:Pregnancy Complications / Q000209:etiology; D013530:Surgical Wound Infection / Q000209:etiology / Q000517:prevention & control; D013636:Tanzania; D013997:Time Factors; D019037:Urban Health Services
D000900:Anti-Bacterial Agents